Jonathan Piazza - 02 May 2022 Form 4 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role: Chief Financial Officer
Signature: /s/ Jeffrey C. Pepe, Attorney-in-Fact
Issuer symbol: SPRY
Transactions as of: 02 May 2022
Net transactions value: $0
Form type: 4
Filing time: 04 May 2022, 17:16:04 UTC
Previous filing: 02 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SPRY	Common Stock	Award	$0	+43,691	+171%	$0.000000	69,225	02 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SPRY	Stock Option (right to buy)	Award	$0	+87,383		$0.000000	87,383	02 May 2022	Common Stock	87,383	$3.15	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
F2	The shares subject to the option will vest on May 2, 2023.